[1]刘晓鸣,卢思广,薛凌宇,等.原发性肾病综合征患儿血淋巴细胞凋亡、增殖及地塞米松对其作用[J].实用儿科临床杂志,2004, 19(9): 741-743.
[2]罗晓菊,李 秋.儿童肾病综合征体液免疫指标与疗效观察[J].重庆医学, 2005,34(2):171-172.
[3]刘扬东.胸腺素α1在肿瘤治疗中的应用进展[J].中国肿瘤生物治疗杂志,2001,8(2):148-149.
[4]中华医学会儿科学分会肾脏病学组.小儿肾小球疾病的临床分类、诊断及治疗[J].中华儿科杂志,2001,39 (12):746-749.
[5]Hulton SA,Shah V,Byrne MR,et al.Lymphocyte subpopulations,interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome[J].Pediatr Nephrol,1994,8(2):135-139.
[6]Zhang P,Chan J,Dragoi AM,et al. Activation of IKK by Tα1 requires the TRAF6 signalling pathway[J].EMBO Rep,2005,6(6):531-537.
[7]姚 磊,向 阳,康 玲,等.肾病综合征患者血清Ig和补体C3的测定及临床意义探讨[J].重庆医学,2006,35(18):1656-1657.
[8]Imai H, Hamai K, Komatsuda M, et al. IgG subclasses in patients with membranoproliferative glomerulo nephritis, membranous nephropathy, and lupus nephritis[J].Kidney Int,1997,51(1):270-276.
[9]Izumi T,Hyodo T,Kikuchi Y, et al. An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome[J].Am J Kidney Dis,2005,46(4):e59-63.